Tarsus Pharmaceuticals, Inc. [TARS] - Tarsus Pharmaceuticals / iRenix Medical merger

Tarsus Pharmaceuticals, Inc. has entered into a definitive merger agreement to acquire iRenix Medical, Inc. for $37.5 million in cash and 607,093 shares of common stock, with potential milestone payments of up to $490 million based on future regulatory and sales achievements.

View source filing ↗